University of Hertfordshire Research Archive

        JavaScript is disabled for your browser. Some features of this site may not work without it.

        Browse

        All of UHRABy Issue DateAuthorsTitlesThis CollectionBy Issue DateAuthorsTitles

        Arkivum Files

        My Downloads
        View Item 
        • UHRA Home
        • University of Hertfordshire
        • Research publications
        • View Item
        • UHRA Home
        • University of Hertfordshire
        • Research publications
        • View Item

        Making anti-thrombotic bypass vessels from selected populations of vascular smooth muscle cells

        View/Open
        Heart_2010_Al_Dhanji.docx (Unknown, 41Kb)
        Author
        Dhanji, A.A.
        Ali, F.Y.
        MacKenzie, Louise Susan
        Shipolini, A.
        Mitchell, J.A.
        Warner, T.D.
        Attention
        2299/15425
        Abstract
        Objectives: Vein grafts are commonly used for coronary artery bypass surgery but poor long-term patency and high failure rate make the idea of ‘designer’ bypass vessels attractive. Here we have investigated the possibility of forming bypass vessels from populations of vascular smooth muscle cells (VSMCs) selected for their anti-thrombotic potential. Methods: Clonal populations of rat VSMCs were derived and characterised for their morphology, protein expression and mediator production. Selected cells were also seeded into vascular scaffolds derived by decellularising rat aortae and cultured for periods of up to 40 days. Results: Clone 5 was found to be the optimal clone due to its ability to produce the anti-platelet hormone prostaglandin (PG) I2 and inhibit platelet activation. In experiments combining the synthetic vessels with platelets, a notable inhibition of platelet activation was seen with a reduction in platelet aggregation (72±4% to 31±9%) (Abstract 024 Figure 1), adhesion (43±2% to 19±6%) (Abstract 024 Figure 2), decreased production of thromboxane A2 (58±8 ng/ml to 31±3 ng/ml) and increased prostaglandin I2 production (0.6±0.5 ng/ml to 5.5±0.8 ng/ml), in response to collagen (3 µg/ml). Conclusions: These results demonstrate that clonal VSMC populations with favourable characteristics, such as the production of anti-thrombotic PGI2 can be isolated and used to produce anti-thrombotic vessels. This raises the possibility of producing vessels for bypass surgery by the simple seeding of selected VSMC populations into inert vascular scaffolds. Keywords: anti-thrombotic; bypass; smooth muscle
        Publication date
        2010-06
        Published in
        Heart
        Published version
        https://doi.org/10.1136/hrt.2010.195941.24
        Other links
        http://hdl.handle.net/2299/15425
        Metadata
        Show full item record
        Keep in touch

        © 2019 University of Hertfordshire

        I want to...

        • Apply for a course
        • Download a Prospectus
        • Find a job at the University
        • Make a complaint
        • Contact the Press Office

        Go to...

        • Accommodation booking
        • Your student record
        • Bayfordbury
        • KASPAR
        • UH Arts

        The small print

        • Terms of use
        • Privacy and cookies
        • Criminal Finances Act 2017
        • Modern Slavery Act 2015
        • Sitemap

        Find/Contact us

        • T: +44 (0)1707 284000
        • E: ask@herts.ac.uk
        • Where to find us
        • Parking
        • hr
        • qaa
        • stonewall
        • AMBA
        • ECU Race Charter
        • disability confident
        • AthenaSwan